Menactra – Meningococcal Vaccine (India)

Menactra is a widely used meningococcal vaccine that helps protect against life-threatening meningococcal infections that can cause meningitis and septicemia. Manufactured in India, this vaccine is part of routine immunization programs and is essential for travelers, students, and individuals in high-risk settings.

The vaccine is recommended for use in:

Infants (9 months and older) and adolescents for routine immunization
Travelers to meningitis-prone regions, including sub-Saharan Africa and Hajj pilgrims
People with weak immune systems, asplenia, or specific medical conditions
College students, military personnel, and individuals in crowded living conditions
🔹 Key Benefits:
✔ Prevents meningitis and bloodstream infections caused by Neisseria meningitidis
✔ Provides long-term immunity against A, C, Y, and W strains
✔ WHO-recommended for routine immunization and epidemic control
✔ Essential for travelers to high-risk areas
✔ Helps reduce the spread of meningococcal disease in crowded environments

🔹 Indications:

Routine vaccination for infants, children, and adolescents
Travel immunization for regions with high meningococcal disease risk
Individuals with asplenia or weakened immune systems
University students, military recruits, and healthcare workers
Meningitis outbreak control in public health programs
⚠️ Precautions:

Must be administered under medical supervision
Common side effects include pain at the injection site, mild fever, headache, or fatigue
Not recommended for individuals with severe allergic reactions to meningococcal vaccines
Rare serious reactions include severe allergic responses or fainting
📦 Packaging: 1 dose (India, 260,000)